Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1053/j.ajkd.2020.12.003 http://scihub22266oqcxt.onion/10.1053/j.ajkd.2020.12.003 33388404!7946342!33388404     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Am+J+Kidney+Dis 2021 ; 77 (5): 777-785 Nephropedia Template TP {{tp|p=33388404|t=2021. Practicing With Uncertainty: Kidney Transplantation During the COVID-19 Pandemic |pdf=|usr=}}{{33388404}} gab.com Text Practicing With Uncertainty: Kidney Transplantation During the COVID-19 Pandemic JO: Am J Kidney Dis http://www.kidney.de/pget.php?&tw=1&pmid=33388404 #FOAvip The coronavirus disease 2019 (COVID-19) pandemic required transplant nephrologists, surgeons, and care teams to make decisions about the full spectrum of transplant program operations and clinical practices in the absence of experience or data. Initially, across the country, there was a reduction in kidney transplant procedures and a striking pause in the conduct of living donation and living-donor transplant surgeries. Aspects of candidate evaluation and follow-up rapidly converted to telehealth. Months into the pandemic, much has been learned from experiences worldwide, yet many questions remain. In this Perspective, we reflect on some of the practice decisions made by the transplant community in the initial response to the pandemic and consider lessons learned, including those related to the risks, benefits, and logistical considerations of proceeding with versus delaying deceased-donor transplantation, living donation, and living-donor transplantation during the pandemic. We review the evolution of therapeutic strategies for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and their use in transplant recipients, current consensus related to immunosuppression management in infected transplant recipients, and emerging information on vaccination against SARS-CoV-2. We share our thoughts on research priorities, discuss the areas in which we are still practicing with uncertainty, and look ahead to the next phase of the pandemic response. Twit Text FOAVip Practicing With Uncertainty: Kidney Transplantation During the COVID-19 Pandemic ????Am J Kidney Dis http://www.kidney.de/pget.php?&tw=1&pmid=33388404 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33388404 #FOAvip English Wikipedia <ref>{{Cite pmid|33388404}}</ref> Practicing With Uncertainty: Kidney Transplantation During the COVID-19 Pandemic #MMPMID33388404 Lentine KL; Mannon RB; Josephson MA Am J Kidney Dis 2021[May]; 77 (5): 777-785 PMID33388404show ga The coronavirus disease 2019 (COVID-19) pandemic required transplant nephrologists, surgeons, and care teams to make decisions about the full spectrum of transplant program operations and clinical practices in the absence of experience or data. Initially, across the country, there was a reduction in kidney transplant procedures and a striking pause in the conduct of living donation and living-donor transplant surgeries. Aspects of candidate evaluation and follow-up rapidly converted to telehealth. Months into the pandemic, much has been learned from experiences worldwide, yet many questions remain. In this Perspective, we reflect on some of the practice decisions made by the transplant community in the initial response to the pandemic and consider lessons learned, including those related to the risks, benefits, and logistical considerations of proceeding with versus delaying deceased-donor transplantation, living donation, and living-donor transplantation during the pandemic. We review the evolution of therapeutic strategies for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and their use in transplant recipients, current consensus related to immunosuppression management in infected transplant recipients, and emerging information on vaccination against SARS-CoV-2. We share our thoughts on research priorities, discuss the areas in which we are still practicing with uncertainty, and look ahead to the next phase of the pandemic response. |*COVID-19/epidemiology/prevention & control[MESH] |*Critical Pathways/organization & administration/trends[MESH] |*Kidney Failure, Chronic/epidemiology/surgery[MESH] |Clinical Decision-Making[MESH] |Humans[MESH] |Immunosuppression Therapy/*methods[MESH] |Infection Control/methods[MESH] |Kidney Transplantation/*methods[MESH] |SARS-CoV-2[MESH] |Telemedicine/methods[MESH] |Time-to-Treatment[MESH] |Tissue Donors/statistics & numerical data[MESH]Practicing With Uncertainty: Kidney Transplantation During the COVID-1(epmc).pdf DeepDyve Pubget Overpricing